4791 - 4800 of 8620 Results
Title
Year
-
OPENTitle: Is Levodopa Response a Valid Indicator of Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 948End Page: 954Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28406Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8046721Citation Count: 35
-
OPENTitle: Kinase Domain Is a Dynamic Hub for Driving LRRK2 AllosteryJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2020.538219Best OA location URL: https://doi.org/10.3389/fnmol.2020.538219Citation Count: 23
- Cerebellar resting-state functional connectivity in Parkinson's disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient level2019OPENTitle: Cerebellar resting-state functional connectivity in Parkinson's disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient levelJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 22Issue #:Start Page: 101720End Page: 101720Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101720Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101720Citation Count: 46
- NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy2020OPENTitle: NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 3Start Page: 1762End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1909110117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1762.full.pdfCitation Count: 112
- Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease2019OPENTitle: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6589361Citation Count: 23
- Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System2019OPENTitle: Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility SystemJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 11Issue #: 1Start Page: 301End Page: 309Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2019.01.011Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.dadm.2019.01.011Citation Count: 50
- Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies2020OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 503End Page: 512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25824Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7719613Citation Count: 109
- OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial2019OPENTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/record/3832127Citation Count: 17
- Identification of a nanomolar affinity α-synuclein fibril imaging probe by ultra-high throughput in silico screening2020OPENTitle: Identification of a nanomolar affinity α-synuclein fibril imaging probe by ultra-high throughput in silico screeningJournal Name: Chemical SciencePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 47Start Page: 12746End Page: 12754Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1039/d0sc02159hBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2020/sc/d0sc02159hCitation Count: 42
- No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's disease2019OPENTitle: No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 87Issue #:Start Page: 140.e19End Page: 140.e22Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.11.006Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0197458019303951Citation Count: 13